Long term storage of dry versus frozen RNA for next generation molecular studies von Seelenfreund, Eric, Robinson, William A, Amato, Carol M, Tan, Aik-Choon, Kim, Jihye, Robinson, Steven E

Volltext

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma von Hintzsche, Jennifer D, Gorden, Nicholas T, Amato, Carol M, Kim, Jihye, Wuensch, Kelsey E, Robinson, Steven E, Applegate, Allison J, Couts, Kasey L, Medina, Theresa M, Wells, Keith R, Wisell, Joshua A, McCarter, Martin D, Box, Neil F, Shellman, Yiqun G, Gonzalez, Rene C, Lewis, Karl D, Tentler, John J, Tan, Aik Choon, Robinson, William A

Volltext

MicroRNA-137 Targets Microphthalmia-Associated Transcription Factor in Melanoma Cell Lines von BEMIS, Lynne T, CHEN, Robert, AMATO, Carol M, CLASSEN, Elizabeth H, ROBINSON, Steven E, COFFEY, David G, ERICKSON, Paul F, SHELLMAN, Yiqun G, ROBINSON, William A

Volltext

Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma von Chen, Robert W., Bemis, Lynne T., Amato, Carol M., Myint, Han, Tran, Hung, Birks, Diane K., Eckhardt, S. Gail, Robinson, William A.

Volltext

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine von Dart, Chiara R., Mukherjee, Nabanita, Amato, Carol M., Goulding, Anabel, MacBeth, Morgan, Van Gulick, Robert, Couts, Kasey L., Lambert, James R., Norris, David A., Robinson, William A., Shellman, Yiqun G.

Volltext

IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics von Hintzsche, Jennifer D, Yoo, Minjae, Kim, Jihye, Amato, Carol M, Robinson, William A, Tan, Aik Choon

Volltext

Circulating CD8+ mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patients von Vorwald, Victoria M, Davis, Dana M, Van Gulick, Robert J, Torphy, Robert J, Borgers, Jessica SW, Klarquist, Jared, Couts, Kasey L, Amato, Carol M, Cogswell, Dasha T, Fujita, Mayumi, Castleman, Moriah J, Davis, Timothy, Lozupone, Catherine, Medina, Theresa M, Robinson, William A, Gapin, Laurent, McCarter, Martin D, Tobin, Richard P

Volltext

Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma von Khushalani, Nikhil I, Vassallo, Melinda, Goldberg, Judith D, Eroglu, Zeynep, Kim, Younchul, Cao, Biwei, Ferguson, Robert, Monson, Kelsey R, Kirchhoff, Tomas, Amato, Carol M, Burke, Paulo, Strange, Ann, Monk, Emily, Gibney, Geoffrey Thomas, Kudchadkar, Ragini, Markowitz, Joseph, Brohl, Andrew S, Pavlick, Anna, Richards, Alison, Woods, David M, Weber, Jeffrey

Volltext

A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance von Mitra, Ankita, Thompson, Brian, Strange, Ann, Amato, Carol M, Vassallo, Melinda, Dolgalev, Igor, Hester-McCullough, Jonathan, Muramatsu, Tomoaki, Kimono, Diana, Puranik, Amrutesh S, Weber, Jeffrey S, Woods, David

Volltext

Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity von Newell, Felicity, Wilmott, James S., Johansson, Peter A., Nones, Katia, Addala, Venkateswar, Mukhopadhyay, Pamela, Broit, Natasa, Amato, Carol M., Van Gulick, Robert, Kazakoff, Stephen H., Patch, Ann-Marie, Koufariotis, Lambros T., Lakis, Vanessa, Leonard, Conrad, Wood, Scott, Holmes, Oliver, Xu, Qinying, Lewis, Karl, Medina, Theresa, Gonzalez, Rene, Saw, Robyn P. M., Spillane, Andrew J., Stretch, Jonathan R., Rawson, Robert V., Ferguson, Peter M., Dodds, Tristan J., Thompson, John F., Long, Georgina V., Levesque, Mitchell P., Robinson, William A., Pearson, John V., Mann, Graham J., Scolyer, Richard A., Waddell, Nicola, Hayward, Nicholas K.

Volltext

CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy von Thompson, Brian, Strange, Ann, Amato, Carol M, Hester-McCullough, Jonathan, Sarnaik, Amod A, Weber, Jeffrey S, Woods, David M

Volltext

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma von Nassar, Kelsey W., Hintzsche, Jennifer D., Bagby, Stacey M., Espinoza, Veronica, Langouet-Astrie, Christophe, Amato, Carol M., Chimed, Tugs-Saikhan, Fujita, Mayumi, Robinson, William, Tan, Aik Choon, Schweppe, Rebecca E.

Volltext

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells von Mukherjee, Nabanita, Skees, Jenette, Todd, Kaleb J., West, Drake A., Lambert, Karoline A., Robinson, William A., Amato, Carol M., Couts, Kasey L., Van Gulick, Robert, MacBeth, Morgan, Nassar, Kelsey, Tan, Aik-Choon, Zhai, Zili, Fujita, Mayumi, Bagby, Stacey M., Dart, Chiara R., Lambert, James R., Norris, David A., Shellman, Yiqun G.

Volltext

Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics von Mukherjee, Nabanita, Dart, Chiara R., Amato, Carol M., Honig-Frand, Adam, Lambert, James R., Lambert, Karoline A., Robinson, William A., Tobin, Richard P., McCarter, Martin D., Couts, Kasey L., Fujita, Mayumi, Norris, David A., Shellman, Yiqun G.

Volltext

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma von Mukherjee, Nabanita, Strosnider, Andrew, Vagher, Bay, Lambert, Karoline A., Slaven, Sarah, Robinson, William A., Amato, Carol M., Couts, Kasey L., Bemis, Judson G. T., Turner, Jacqueline A., Norris, David A., Shellman, Yiqun G.

Volltext

Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy von Amato, Carol M., Hintzsche, Jennifer D., Wells, Keith, Applegate, Allison, Gorden, Nicholas T., Vorwald, Victoria M., Tobin, Richard P., Nassar, Kelsey, Shellman, Yiqun G., Kim, Jihye, Medina, Theresa M., Rioth, Matthew, Lewis, Karl D., McCarter, Martin D., Gonzalez, Rene, Tan, Aik-Choon, Robinson, William A.

Volltext

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma von Mukherjee, Nabanita, Amato, Carol M., Skees, Jenette, Todd, Kaleb J., Lambert, Karoline A., Robinson, William A., Van Gulick, Robert, Weight, Ryan M., Dart, Chiara R., Tobin, Richard P., McCarter, Martin D., Fujita, Mayumi, Norris, David A., Shellman, Yiqun G.

Volltext

DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors von Nielsen, Allison Joy, Albert, Gabriella Kyra, Sanchez, Amelia, Chen, Jiangli, Liu, Jing, Davalos, Andres Sebastian, Geng, Degui, Bradeen, Xander G, Hintzsche, Jennifer D, Robinson, William, McCarter, Martin, Amato, Carol M, Tobin, Richard, Couts, Kasey L, Wilky, Breelyn Ann, Davila, Eduardo

Volltext

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments von Mukherjee, Nabanita, Almeida, Adam, Partyka, Katie A, Lu, Yan, Schwan, Josianna V, Lambert, Karoline, Rogers, Madison, Robinson, William A, Robinson, Steven E, Applegate, Allison J, Amato, Carol M, Luo, Yuchun, Fujita, Mayumi, Norris, David A, Shellman, Yiqun G

Volltext

Gastrointestinal Melanoma or Clear Cell Sarcoma? Molecular Evaluation of 7 Cases Previously Diagnosed as Malignant Melanoma von LYLE, Pamela L, AMATO, Carol M, FITZPATRICK, James E, ROBINSON, William A

Volltext